| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/05/2007 | EP1463760B1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 09/05/2007 | EP1463733B1 Mitotic kinesin inhibitors |
| 09/05/2007 | EP1441724B1 Methods of increasing endogenous testosterone levels |
| 09/05/2007 | EP1345598B1 The use of rosiglitazone for treating psychiatric disorders. |
| 09/05/2007 | EP1093465B1 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 09/05/2007 | EP0757716B1 Dna encoding bradykinin b1 receptor |
| 09/05/2007 | CN101031322A 固体药物制剂 The solid pharmaceutical preparation |
| 09/05/2007 | CN101031321A Perorally administrable antimicrobial composition |
| 09/05/2007 | CN101031291A Compound containing methanol and composition containing at least one nsaid active substance |
| 09/05/2007 | CN101031287A Nanocell drug delivery system |
| 09/05/2007 | CN101029337A Use and method for predicting serotonin re-uptake inhibitor medicine effect by polymorphic site |
| 09/05/2007 | CN101029336A Reagent kit for predicting serotonin re-uptake inhibitor medicine effect |
| 09/05/2007 | CN101028550A Artificial vagina feeder and its production |
| 09/05/2007 | CN101028521A Oral colon positioning feed preparation based on electric spinning superfine nuclear fibre and its making method |
| 09/05/2007 | CN101028519A Pharmaceutical composition for treating immune diseases |
| 09/05/2007 | CN101028518A Medicinal composition containing silver ester medicine and ibobulodine |
| 09/05/2007 | CN101028517A Composition containing ADP receptor antagonist and silver ester medicine |
| 09/05/2007 | CN101028516A Medicine preparation for oral cavity |
| 09/05/2007 | CN101028283A Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 09/05/2007 | CN101028249A Anti-cancer composition containing neoformative vascular inhibitor and alkylating agent |
| 09/05/2007 | CN101028248A Anti-cancer composition containing vascular inhibitor and topographic enzyme inhibitor |
| 09/05/2007 | CN101028247A Anti-cancer composition containing neoformative vascular inhibitor and alkaloid |
| 09/05/2007 | CN101028246A Anti-cancer composition containing neoformative vascular inhibitor and hormone medicine |
| 09/05/2007 | CN101028245A Anti-cancer composition with neoformative vascular inhibitor and phosphoinositide 3-inositol inhibitor carrier |
| 09/05/2007 | CN101028244A Anti-cancer composition containing neoformative vascular inhibitor and antimetabolite |
| 09/05/2007 | CN101028243A Anti-cancer composition containing neoformative vascular inhibitor and Eps mycin |
| 09/05/2007 | CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3 |
| 09/05/2007 | CN100335461C Arylsulfonanilide ureas |
| 09/05/2007 | CN100335136C Pharmaceutical composition having reduced tendency for drug crystallization |
| 09/05/2007 | CN100335132C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/05/2007 | CN100335123C Method for improving oral drug living thing availability, composition and reagent box |
| 09/05/2007 | CN100335060C Combination of cytochome p450 dependent protease inhibitors |
| 09/05/2007 | CN100335040C Rapidly disintegrating tablet comprising acid-sensitive active ingredient |
| 09/05/2007 | CN100335015C Artificial kidney having function of metabolizing profein and method of constituting same |
| 09/04/2007 | US7266483 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 09/04/2007 | US7265261 Non-human animal model of systemic lupus erythematosus |
| 09/04/2007 | US7265260 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors |
| 09/04/2007 | US7265221 Pyrrolo[2,3-d]pyrimidine compounds |
| 09/04/2007 | US7265150 E.g., [(2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-hydroxymethylpyrrolidine; (2S)-1-(1, 2-dioxo-3,3-dimethylpentyl)-2-pyrrolidinetetrazole; (2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-pyrrolidinecarbonitrile; and 2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-aminocarbonyl piperidine |
| 09/04/2007 | US7265142 Materials and methods for the treatment of hypertension and angina |
| 09/04/2007 | US7265139 RXR activating molecules |
| 09/04/2007 | US7265134 Tyrosine kinase inhibitors |
| 09/04/2007 | US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 09/04/2007 | US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis |
| 09/04/2007 | US7265099 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 09/04/2007 | US7265097 Delivering therapeutic formulation containing sulphated chitinous polymer as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 09/04/2007 | US7265087 Exendin improves β-cell response in subjects with impaired glucose tolerance |
| 09/04/2007 | US7264953 Mutant proteinase-inhibitors and uses thereof |
| 09/04/2007 | US7264940 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor |
| 09/04/2007 | US7264826 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 09/04/2007 | US7264825 Pharmaceutical preparation with retarding active ingredient release, method for its production and its use |
| 09/04/2007 | US7264813 Therapeutic uses of Dunaliella powder |
| 09/04/2007 | US7264799 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient |
| 09/04/2007 | US7264798 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 09/04/2007 | CA2374688C Composite laminate and process for producing it |
| 09/04/2007 | CA2329665C Treatment of depression and pharmaceutical preparations therefor |
| 09/04/2007 | CA2232450C Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 09/04/2007 | CA2215329C Colorectal chemoprotective composition and method for preventing colorectal cancer |
| 09/04/2007 | CA2134479C Laser treatment |
| 08/30/2007 | WO2007098390A2 Method for treating resistant hypertension |
| 08/30/2007 | WO2007097929A1 Compounds and methods for treatment of stroke |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097205A1 Eyedrops |
| 08/30/2007 | WO2007097010A1 Substance fki-2342 and process for production thereof |
| 08/30/2007 | WO2007096601A2 Antimicrobial formulations comprising a quinone and a copper salt |
| 08/30/2007 | WO2007096173A1 Combinations of steroids and methylxanthine compounds |
| 08/30/2007 | US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces |
| 08/30/2007 | US20070203246 Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications |
| 08/30/2007 | US20070203215 Methods & Compositions For Enhancing Pharmaceutical Treatments |
| 08/30/2007 | US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070203182 Alpha-Aminoamide Derivatives Useful In The Treatment Of Restless Legs Syndrome And Addictive Disorders |
| 08/30/2007 | US20070203119 Combination Therapy For The Treatment Of Schizophrenia |
| 08/30/2007 | US20070203098 Pten Inhibitors |
| 08/30/2007 | US20070203088 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease |
| 08/30/2007 | US20070203068 Stimulation of beta cell proliferation |
| 08/30/2007 | US20070202575 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent |
| 08/30/2007 | US20070202516 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 08/30/2007 | US20070202503 Pharmaceutical Composition Of (+)-Erythro-Mefloquine And Its Use |
| 08/30/2007 | US20070202208 Anti-Inflammatory Pharmaceutical Compositions For Reducing Inflammation And The Treatment Or Prevention Of Gastric Toxicity |
| 08/30/2007 | US20070202204 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202196 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202194 Preparation for the prevention and/or treatment of vascular disorders |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| 08/30/2007 | US20070202116 Staphylococcal infections using glycopeptide antibiotic eg vancomycin |
| 08/30/2007 | US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 08/30/2007 | US20070202101 Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/30/2007 | US20070202078 Method Of Treating Viral Infections |
| 08/30/2007 | US20070199898 Dialysate of peritoneal dialysis and its preparation method |
| 08/30/2007 | DE102006008321A1 Mittel zur Behandlung von Infektionen mit Influenzaviren Agents for the treatment of infections with influenza viruses |
| 08/30/2007 | DE10045374B4 Verfahren zur Herstellung von Mikroteilchen mit verzögerter Freisetzung Process for the preparation of sustained release microparticles |
| 08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
| 08/30/2007 | CA2643130A1 Compounds and methods of treating disorders associated with activation of metachromatic cells |
| 08/30/2007 | CA2642587A1 Compounds and methods for treatment of stroke |
| 08/30/2007 | CA2640131A1 Combinations of steroids and methylxanthine compounds |
| 08/29/2007 | EP1826198A1 Method for the synthesis of the sodium salt of retinoyl-cysteic acid and retinoyl-cysteine sulfinic acid |
| 08/29/2007 | EP1826197A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 08/29/2007 | EP1825854A1 MEDICINAL COMPOSITION CONTAINING FBPase INHIBITOR |